Taofeek Kunle Owonikoko is an American physician who is Professor and Vice-Chair for Faculty Development, Department of Haematology and Medical Oncology at the Winship Cancer Institute.
[citation needed] Whilst in Germany Owonikoko earned a doctoral degree in anatomical pathology.
[1] In 2001 Owonikoko joined Johns Hopkins University as a postdoctoral fellow, where he worked in molecular imaging.
[citation needed] He leads clinical trials into novel immunotherapy drugs, which can be used to treat aggressive and recurrent cancers.
[4] He has studied the efficacy of talazoparib as a treatment for small cell lung cancer patients with homologous recombination repair deficiency.